Marimed (MRMD) Other Non-Current Assets (2013 - 2026)
Marimed's (MRMD) quarterly Other Non-Current Assets came in at $950000.0 in Q1 2026, down 14.87% year-on-year from $1.1 million in Q1 2025, and up 2.04% on a QoQ basis from $931000.0 in Q4 2025.
Marimed (MRMD) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Marimed (MRMD) has 14 years of Other Non-Current Assets data on file, last reported at $950000.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 14.87% year-over-year to $950000.0 in Q1 2026; TTM through Mar 2026 was $950000.0, a 14.87% decrease from a year earlier, with the FY2025 full-year figure at $931000.0, down 37.93% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $950000.0, up from $931000.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for MRMD reached as high as $13.0 million in Q1 2024 and fell as low as $98000.0 in Q1 2022.
- Historically, Other Non-Current Assets has averaged $4.2 million across 5 years, with a median of $1.1 million in 2025.
- Across the five-year window, Other Non-Current Assets soared 1229.59% in 2023 and plunged 91.39% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $1.0 million in 2022, then soared by 1124.32% to $12.5 million in 2023, then slumped by 88.04% to $1.5 million in 2024, then plunged by 37.93% to $931000.0 in 2025, then increased by 2.04% to $950000.0 in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $950000.0 in Q1 2026, $931000.0 in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Marimed | 23.85 Mn | 14.02 Mn | 15.28 Mn | 950,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 950,000.00 |
| Dec 31, 2025 | 931,000.00 |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 1.50 Mn |
| Sep 30, 2024 | 11.10 Mn |
| Jun 30, 2024 | 11.10 Mn |
| Mar 31, 2024 | 12.96 Mn |
| Dec 31, 2023 | 12.54 Mn |
| Sep 30, 2023 | 11.61 Mn |
| Jun 30, 2023 | 1.42 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 1.01 Mn |
| Jun 30, 2022 | 491,000.00 |
| Mar 31, 2022 | 98,000.00 |
| Dec 31, 2021 | 98,000.00 |
| Sep 30, 2021 | 97,951.00 |
| Jun 30, 2021 | 97,950.00 |